Literature DB >> 33196980

An Investigation of the Eating Concerns Scale of the Minnesota Multiphasic Personality Inventory-3 (MMPI-3) in a Postoperative Bariatric Surgery Sample.

Ryan J Marek1, Katy Martin-Fernandez2, Leslie J Heinberg3, Yossef S Ben-Porath2.   

Abstract

Eating pathology is common pre-operatively and continues to be prevalent following bariatric surgery. A new version of the Minnesota Multiphasic Personality Inventory (MMPI), the MMPI-3, contains a new scale called Eating Concerns (EAT) that aims to assess problematic eating behaviors. The current investigation seeks to establish preliminary convergent validity of the MMPI-3 EAT scale in a postoperative bariatric surgery sample. Thirty-eight consecutive participants took the MMPI-3 and the Eating Disorder Examination-Questionnaire (EDE-Q). Higher MMPI-3 EAT scale scores were meaningfully associated with %Weight Regain (r = .37) and scale scores on the EDE-Q [Eating Concerns (r = .67), Weight Concerns (r = .39), Shape Concerns (r = .54), and the EDE total score (r = .59)]. Initial examination of the EAT Specific Problem Scale of the MMPI-3 yields good clinical utility in assessing eating pathology in a postoperative bariatric surgery sample.

Entities:  

Keywords:  Assessment; Binge; Body image; Eating disorders; MMPI-3; Personality

Mesh:

Year:  2020        PMID: 33196980     DOI: 10.1007/s11695-020-05113-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  2 in total

1.  Criterion and Incremental Validity of the MMPI-3 Eating Concerns Scale in a University Sample.

Authors:  Nela Vaňousová; Tiffany A Brown; Martin Sellbom
Journal:  J Clin Psychol Med Settings       Date:  2021-03-29

2.  Examination of the Reliability and Validity of the Minnesota Multiphasic Personality Inventory-3 (MMPI-3) in a Preoperative Bariatric Surgery Sample.

Authors:  Ashleigh A Pona; Ryan J Marek; Eva Panigrahi; Yossef S Ben-Porath
Journal:  J Clin Psychol Med Settings       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.